首页> 外国专利> Mannose-receptor selective lysinylated cationic amphiphiles and a process for preparation thereof

Mannose-receptor selective lysinylated cationic amphiphiles and a process for preparation thereof

机译:甘露糖受体选择性赖氨酰化阳离子两亲物及其制备方法

摘要

The present invention relates to the mannose-receptor selective lysinylated cationic amphiphile and a process for preparation thereof. The compounds of the present invention can target DNA vaccines to antigen presenting cells (APCs) such as macrophages and dendritic cells (DCs), via mannose receptors expressed on the cell surface of APCs. The cationic amphiphiles disclosed herein show enhanced cellular and humoral immune response compared to their mannosyl counterparts in genetic immunization in mice. The present invention discloses that immunization with electrostatic complexes (lipoplexes) of DNA vaccines encoding melanoma antigens (gp100 and tyrosinase) and liposome of the presently described novel lysinylated cationic amphiphiles with mannose-mimicking shikimoyl head-groups provides long-lasting (100 days post melanoma tumor challenge) protective immunity in all immunized mice. Cationic amphiphiles with mannose-mimicking shikimoyl head-groups described in the present invention are likely to find future applications in the field of genetic immunization.
机译:本发明涉及甘露糖受体选择性赖氨酰化阳离子两亲物及其制备方法。本发明的化合物可以通过在APC细胞表面表达的甘露糖受体将DNA疫苗靶向抗原呈递细胞(APC),例如巨噬细胞和树突状细胞(DC)。与它们的甘露糖基对应物相比,本文公开的阳离子两亲物在小鼠的基因免疫中显示出增强的细胞和体液免疫反应。本发明公开了用静电复合物(脂质复合物)免疫编码甘露糖模拟的sh草酰头部的目前描述的新型赖氨酰化阳离子两亲物的编码黑素瘤抗原(gp100和酪氨酸酶)和脂质体的DNA疫苗的持久性(在黑素瘤后100天)肿瘤攻击)在所有免疫小鼠中的保护性免疫。在本发明中描述的具有模仿甘露糖的sh草酰基头基的阳离子两亲物可能在基因免疫领域中找到未来的应用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号